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or the presence of RV by enzyme immuno assay (EIA). RV posi-
ive samples were genotyped by Reverse Transcriptase Polymerase
hain Reaction (RT-PCR). Seasonality of RVGE cases was recorded
uring the study period. Severity of the RVGE episodes was mea-
ured using the Vesikari scale, where a score of ≥11was considered
evere.
Results: Of the 534 children enrolled in this study, 491 (91.9%)
ere included in the ﬁnal analysis in the according-to-protocol
ohort; 27.7% (136/491) of subjects were RV positive, 71.5%
351/491) were RV negative and 0.8% (4/491) had unknown RV sta-
us. Of the RV positive subjects, 75% (102/136) of caseswere seen in
hildren <2 years of age. Although RVGE cases occurred through-
ut the year, the peak season was observed between December
007 and March 2008 (65.4%; 89/136). Severe GE cases observed
eforehospitalizationwas79.4% (108/136) inRVpositive and76.1%
267/351) in RV negative subjects (p =0.44). G4 (36.9%) and P[8]WT
77.7%) were the most common RV types detected among RV pos-
tive samples that were genotyped (N=130).
Conclusion: The data generated from this ﬁrst burden of dis-
ase study in Lebanon showed that the AF of Rotavirus in children
5 years of age corresponded to 27.7% of hospitalized GE. Most of
he RV cases (75%) were in children aged <2 years. These baseline
pidemiology data might guide policy makers in initiating nation-
ide public health strategies, including vaccination to reduce the
V disease burden in Lebanese children <5 years of age.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.356
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Background: The incidence of cryptococcosis has increased
ver the past 30 years as the result of the AIDS pandemia and
mmunossuppresive treatments. It has been reported the presence
f resistant strains in vitro to antifungal drugs. The proposed cor-
elation between minimum inhibitory concentration (MIC) of the
solated C. neoformans strains and the clinical course is still contro-
ersial.
The aim of this study was to determine the correlation between
he MICs of ﬂuconazole and amphotericin B for C. neoformans and
he clinical course of cryptococcal meningitis in AIDS patients.
Methods: We performed a prospective study between 2009 y
010 in the Infectious Diseases Hospital (Montevideo, Uruguay)
hat enrolled 33 patients that met the inclusion criteria (adults,
IV positive, cryptococcal meningitis conﬁrmed by isolation of the
trainof cerebroespinalﬂuid). The studywasapprovedby theethics
ommittee of the participating institution.
The identiﬁcation of the strains was performed by phenotipic
tudies. All of isolates belongued to C. neoformans var neoformans.
usceptibility to ﬂuconazol and amphotericin B determined by the
LSI broth microdilution metodology.fectious Diseases 16S (2012) e317–e473
Results: Sambple characteristics: of the 33 patients 21 were
male, all had CD4≤200/mm3, 9 had biochemical and cytological
study of cerebrospinal ﬂuid tests. 24 wrere already had a diagnose
of AIDS andwere no receivingHAART. 4 patients died during hospi-
talization for reasons related to cryptococcal meningitis. The study
of antifungal susceptibility showed MICs of o,25 - 4g /ml to ﬂu-
conazole and 0,03-0,5ug/ml in the amphotericin B. Therefore, no
strain showed in vitro resistance to any of the antifungal agent
tested and futhermore, no established relation between MICs and
clinical outcome.
Conclusion:Determining the susceptibility to antifungal shows
no strains of C. neoformans resistant or clinical problems related
to resistance. No relationship was found between clinical outcome
and antifungalMICs and all the strains in vitro since all strainswere
susceptible. Severe immune deterioration due to the absence to
HAART seems to be the most important determinant for the devel-
opment of the life threatening cryptococcosis in this population.
http://dx.doi.org/10.1016/j.ijid.2012.05.357
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The predictive rule for the management of hospital-acquired
pneumonia in adults by the Japanese Respiratory Society, I-
ROAD, could correctly estimate the severity of Pneumcystis
Pneumonia without human immunodeﬁciency virus infection
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Background: Non-HIV Pneumocystis pneumonia (PCP) could
occur in immunosupressed patients having malignancy or on
immunosuppressive agents. A-DROP system by the Japanese Res-
piratory Society (JRS), CURB-65 score by British Respiratory Society
(BTS) and the Pneumonia Severity Index (PSI) by the Infectious
Disease Society of America (IDSA) are widely used in classifying
patientswith CAP in Japan. Another predictive rule, I-ROAD, is used
for hospital associated pneumonia (HAP) in Japan. We previously
reported that I-ROADcould evaluate correctly the severity of CAPas
well. For the purpose of evaluating how correctly the I-ROAD could
reﬂect the severity of non-HIV PCP, we retrospectively analyzed all
the non-HIV PCP patients.
Methods:Wereviewedall non-HIVPCPpatients admitted toour
department from 2009 to 2011. A total of 23 non-HIV PCP patients
were enrolled in this study. Patients’ characteristics, the severities
of pneumonia, outcomes and the accuracy of predictive rules in
each guideline were evaluated.
Results: A total of 23 non-HIV PCP patients were enrolled in
this study. The patients were 13 males and 10 females. Fourteen
were cured and 9 were dead. Based on A-DROP, 20 of the 23 (87%)
patients were classiﬁed as mild or moderate. Sixteen of 20 (80%)
developed respiratory failure and 8 of the 16 (50%) died. Based
on CURB-65, 21 of 23 patients (91.3%) were evaluated as mild or
moderate. Seventeen of the 21 (81%) developed respiratory failure
and 9 of the 17 (52.9%) died. Based on PSI, 8 of 23 patients (34.8%)
were evaluated as mild or moderate. Four of the 8 (50%) developed
respiratory failure and 1 of the 8 (12.5%) died. However, based on I-
